Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
LYN-005
DRUG
2 trials
Sponsors
Lyndra Inc.
Conditions
Schizoaffective Disorder
Schizophrenia
Schizophrenia Schizoaffective
Phase 2
A Multiple Dose Study to Assess the Safety, Tolerability and PK of Risperidone Extended Release Capsules
Completed
NCT04567524
Lyndra Inc.
Schizophrenia Schizoaffective
Start: 2020-08-13
End: 2020-12-22
Updated: 2023-02-08
Phase 3
Study to Evaluate the Pharmacokinetics (PK) and Safety/Tolerability of Long-Acting Oral LYN-005
Completed
NCT05779241
Lyndra Inc.
Schizoaffective Disorder, Schizophrenia
Start: 2023-04-13
End: 2023-12-01
Updated: 2024-10-24
Related Papers
Long-acting oral weekly risperidone (LYN-005) for schizophrenia in the USA (STARLYNG-1): a multicentre, open-label, non-randomised phase 3 trial.
2025-07-01